Page 10 - HFA Dateline 2022 Q3 Fall

B:8.75"
T:8.5"
S:7"

1 2 3 4 5 6 7 8 9 10

11 12
CAN YOU SOLVE 13 14

15 16 17
18 19 20

21 22 23 24 25
26 27

28 29 30 31
32 33 34 35

36 37
38 39

ACROSS
1. Wine barrel 32. Small hole in lace cloth 16. Pre-Euro currency in Italy
5. Deep fi ssures 35. Central Plains tribe 19. Subway alternative
11. Mideast gulf port 36. Melodic 20. Relax
12. District 37. Towering 23. Human
13. Ripped 38. Reduce 24. New Orleans cuisine
14. Familiar with 39. Spanish cheers 25. Mentally prepares
15. Mean 26. Collared shirts
17. Roost DOWN 27. Instagram post
18. The #1 prescribed prophylaxis for 1. Memorable, as an earworm 28. Ardent enthusiasm
people with hemophilia A without 2. Devotee 29. Brontë heroine Jane
factor VIII inhibitors* 3. Medical fl uids 30. Old Portuguese coins S:9.75" T:11" B:11.25"
* According to IQVIA claims data from various 4. Prepare to propose, perhaps 33. Opposite of WNW
insurance plan types from April 2020 - May 2021 5. PC’s “brain” 34. More than_____ thousand patients have
and accounts for usage in prophylaxis settings 6. Owns †
in the US. been treated with HEMLIBRA worldwide
21. Calendar divs. 7. Concert venue SOLUTIONS
22. Regret 8. See Medication Guide
or talk to your doctor about
23. Banquet hosts (abbr.) 30. Reis, 33. ESE, 34. ten 25. steels, 26. polos, 27. photo, 28. zeal, 29. Eyre,
26. International travel necessity potential _____ effects 16. lira, 19. bus, 20. rest, 23. mortal, 24. Creole,
9. Winter hrs. in Denver and El Paso
28. Check out the _____ treated 10. HEMLIBRA is the only prophylactic 5. CPU, 6. has, 7. arena, 8. side, 9. MSTs, 10. shot, Down: 1. catchy, 2. adorer, 3. serums, 4. kneel,
bleeds data with HEMLIBRA 35. Otoe, 36. ariose, 37. tall, 38. lessen, 39. oles 26. passport, 28. zero, 31. three, 32. eyelet,
31. Number of dosing options treatment offered this way under 18. HEMLIBRA, 21. yrs, 22. rue, 23. MCs,
HEMLIBRA offers the skin 13. tore, 14. used to, 15. cruel, 17. nest, Across: 1. cask, 5. chasms, 11. Aden, 12. parish,
† Number of people with hemophilia A
treated as of October 2021.
Discover more at HEMLIBRA.com/answers

INDICATION & IMPORTANT SAFETY INFORMATION
What is HEMLIBRA?
HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in
adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.
What is the most important information I should know about HEMLIBRA?
HEMLIBRA increases the potential for your blood to clot. People who use activated prothrombin complex concentrate (aPCC;
Feiba ) to treat breakthrough bleeds while taking HEMLIBRA may be at risk of serious side effects related to blood clots.
®
These serious side effects include:
• Thrombotic microangiopathy (TMA), a condition involving blood clots and injury to small
blood vessels that may cause harm to your kidneys, brain, and other organs
• Blood clots (thrombotic events), which may form in blood vessels in your arm, leg, lung, or head
Please see Brief Summary of Medication Guide on following page for Important
Safety Information, including Serious Side Effects.